Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia [0.03%]
走向皮肤癌的预防和早期检测：澳大利亚皮肤癌意识宣传活动的演变
Michelle R Iannacone,Adèle C Green
Michelle R Iannacone
Since the 1980s, Australia's mass-media campaigns promoting skin cancer awareness, namely skin cancer-preventative behaviors and early detection, have targeted the general community as well as high-risk groups, including outdoor workers, sc...
Andrés Perissinotti,Sergi Vidal-Sicart,Omgo Nieweg et al.
Andrés Perissinotti et al.
Supported by a large body of published work, the contribution of nuclear medicine technologies to the assessment of melanoma has been increasing in recent years. Lymphoscintigraphy-assisted sentinel lymph node biopsy and PET are in continuo...
Paolo A Ascierto
Paolo A Ascierto
Until recently, melanoma represented a significant clinical challenge to oncologists. However, the approval in 2011 of ipilimumab, an anti-CTLA4 monoclonal antibody, and vemurafenib, a BRAF inhibitor, completely changed melanoma management,...
Iris Zalaudek,Elvira Moscarella,Caterina Longo et al.
Iris Zalaudek et al.
While the incidence of early-stage melanoma has dramatically increased over the past decades, the incidence and mortality rates of thick melanomas have remained relatively stable during the same period. A number of alternative theories have...
Piotr Rutkowski,Marcin Zdzienicki,Katarzyna Kozak
Piotr Rutkowski
The majority of locoregional relapses of cutaneous melanoma occur as subcutaneous local recurrences/in-transit metastases; subcutaneous metastases (SMs) are also common in distant metastases. SM therapy is challenging and depends on the num...
A melanoma odyssey - a conversation with Vernon Sondak about a career in melanoma treatment and research [0.03%]
黑色素瘤的探索之旅——与Vernon Sondak谈黑色素瘤治疗及研究生涯
Vernon Sondak
Vernon Sondak
VERNON SONDAK* SPEAKS TO LAURA MCGUINNESS, MANAGING COMMISSIONING EDITOR: Vernon Sondak is Chair of the Department of Cutaneous Oncology and Director of Surgical Education at the H Lee Moffitt Cancer Center and Research Institute in Tampa, ...
Paolo A Ascierto,James Larkin
Paolo A Ascierto
Paolo A Ascierto obtained his MD from the University of Naples, Italy, where he earned board certification in oncology. He is currently Director at the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, National Tumor Insti...
Geoffrey T Gibney,Vernon K Sondak,Keiran Sm Smalley
Geoffrey T Gibney
A blood test to identify when melanoma metastasizes: a reality for melanoma management? [0.03%]
检测黑色素瘤转移的血液检查：黑色素瘤管理中的现实吗？
Eleftheria Hatzimichael,Nel Syed,Cristiana Lo Nigro et al.
Eleftheria Hatzimichael et al.
High-risk cutaneous melanoma follow-up: time for more intensive surveillance? [0.03%]
高风险黑色素瘤的随访：更密集监测的时候来了吗？
Michael Davidson,Paul Lorigan,James Larkin
Michael Davidson